Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial by Wang, Eunice S, Prof, Issa, Ghayas C, MD, Erba, Harry P, Prof, Altman, Jessica K, Prof, Montesinos, Pau, MD, DeBotton, Stephane, MD, Walter, Roland B, Prof, Pettit, Kristen, MD, Savona, Michael R, Prof, Shah, Mithun Vinod, MD, Kremyanskaya, Marina, MD, Baer, Maria R, Prof, Foran, James M, Prof, Schiller, Gary, Prof, Adès, Lionel, Prof, Heiblig, Mael, MD, Berthon, Celine, MD, Peterlin, Pierre, MD, Rodríguez-Arbolí, Eduardo, MD, Salamero, Olga, MD, Patnaik, Mrinal M, Prof, Papayannidis, Cristina, MD, Grembecka, Jolanta, Prof, Cierpicki, Tomasz, Prof, Clegg, Bradley, BA, Ray, Joshua, BSc, Linhares, Brian M, PhD, Nie, Kun, PhD, Mitra, Amitava, PhD, Ahsan, Julie Mackey, MS, Tabachri, Marilyn, BSN, Soifer, Harris S, PhD, Corum, Daniel, PhD, Leoni, Mollie, MD, Dale, Stephen, MD, Fathi, Amir T, MD

Get full text

A Phase 2 Study of the Fully Oral Combination of ASTX727 (Decitabine/Cedazuridine) Plus Venetoclax for Older and/or Unfit Patients with Acute Myeloid Leukemia by Bazinet, Alexandre, Garcia-Manero, Guillermo, Short, Nicholas J., Alvarado Valero, Yesid, Abuasab, Tareq, Islam, Md Rabiul, Montalbano, Kathryn, Issa, Ghayas C., Maiti, Abhishek, Yilmaz, Musa, Jain, Nitin, Masarova, Lucia, Kornblau, Steven M., Jabbour, Elias, Montalban-Bravo, Guillermo, Pierce, Sherry, DiNardo, Courtney D., Kadia, Tapan M., Daver, Naval, Konopleva, Marina Y., Kantarjian, Hagop M., Ravandi, Farhad

Get full text